化瘀消栓汤联合血管紧张素转换酶抑制剂治疗老年高血压合并腔隙性脑梗死临床研究
DOI:
CSTR:
作者:
作者单位:

作者简介:

通讯作者:

中图分类号:

R259;R544

基金项目:

河南省科技攻关计划资助项目(222102310018);安阳市2022年科技发展计划资助项目(2022C01SP102)


Clinical Study on Huayu Xiaoshuan Decoction Combined with Angiotensin-Converting Enzyme Inhibitors for Elderly Hypertension Complicated by Lacunar Infarction
Author:
Affiliation:

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
  • 文章评论
    摘要:

    目的:观察化瘀消栓汤联合血管紧张素转换酶抑制剂(ACEI) 治疗老年高血压合并腔隙性脑梗死 的临床疗效及对血压昼夜节律、大脑血流灌注、侧支循环及血管周围间隙的影响。方法:选择2022年1月— 2023年12月安阳市中医院收治的120例老年高血压合并腔隙性脑梗死患者,采用随机数字表法分为对照组和 研究组各60例。研究过程中对照组脱落1例,研究组脱落2例。对照组采用常规对症治疗方案同时加用盐酸贝 那普利片治疗,研究组在对照组治疗基础上加用化瘀消栓汤治疗。2组疗程均为3个月。比较2组临床疗效及 不良反应,以及治疗前后中医证候评分、血压昼夜节律[24 h平均收缩压/舒张压(SBP/DBP)、日间平均SBP/ DBP、夜间平均SBP/DBP、夜间SBP/DBP下降率以及SBP/DBP负荷值]、脑血流灌注情况[脑前动脉(ACA) 和脑中动脉(MCA) 的平均血流速度(Vm) 和搏动指数(PI)]、美国介入和治疗神经放射学协会/介入放射 学协会(ASITN/SIR) 侧支循环评分和血管周围间隙评分。结果:研究组总有效率为96.54%(56/58),对照组 为83.04% (49/59),2组比较,差异有统计学意义(P<0.05)。治疗后,2组头晕眼花、胸痛、肢麻、心悸、 气短、乏力、自汗等证候评分及总分均较治疗前降低(P<0.05),且研究组上述各项评分均低于对照组(P< 0.05)。治疗后,2组24 h平均SBP/DBP、日间平均SBP/DBP、夜间平均SBP/DBP水平以及SBP/DBP负荷值与治 疗前比较,差异均无统计学意义(P>0.05);2组夜间SBP/DBP下降率均较治疗前提高(P<0.05),且研究组 下降率高于对照组(P<0.05)。治疗后,2组ACA Vm和MCA Vm水平均较治疗前升高(P<0.05),且研究组 2项指标水平均高于对照组(P<0.05);ACA PI和MCA PI值均较治疗前降低(P<0.05),且研究组2项指标 值均低于对照组(P<0.05)。治疗后,2组ASITN/SIR 侧支循环评级均较治疗前改善(P<0.05),且研究组 ASITN/SIR侧支循环评级优于对照组(P<0.05)。治疗后,2组血管周围间隙评分均较治疗前降低(P<0.05), 且研究组评分低于对照组(P<0.05)。2组不良反应发生率比较,差异无统计学意义(P>0.05)。结论:化瘀 消栓汤联合ACEI制剂治疗高血压合并腔隙性脑梗死患者有助于缓解临床症状,有效调节血压昼夜节律,降低 血压变异性,改善脑血流灌注并促进侧支循环,减少血管周围间隙,提高临床疗效。

    Abstract:

    Abstract:Objective:To observe the clinical efficacy of Huayu Xiaoshuan Decoction combined with angiotensinconverting enzyme inhibitor (ACEI) in the treatment of elderly hypertension complicated by lacunar infarction,and to explore its effects on blood pressure circadian rhythm, cerebral blood perfusion, collateral circulation, and perivascular spaces. Methods: A total of 120 elderly patients with hypertension complicated by lacunar infarction admitted to Anyang Traditional Chinese Medicine Hospital from January 2022 to December 2023 were selected and randomly divided into the control group and the study group using the random number table method,with 60 cases in each group. During the study, one case dropped out from the control group and two cases from the study group. The control group received routine symptomatic treatment plus Benazepril Hydrochloride Tablets, while the study group received Huayu Xiaoshuan Decoction in addition to the treatment of the control group. The treatment course for both groups was three months. The clinical efficacy and the incidence of adverse reactions, as well as traditional Chinese medicine syndrome scores, blood pressure circadian rhythm [24-hour mean systolic/diastolic blood pressure (SBP/ DBP), daytime mean SBP/DBP, nighttime mean SBP/DBP, nighttime SBP/DBP reduction rate, SBP/DBP load values], cerebral blood perfusion parameters [mean flow velocity (Vm) and pulsatility index (PI) of the anterior cerebral artery (ACA) and middle cerebral artery (MCA)], American Society of Interventional and Therapeutic Neuroradiology/Society of Interventional Radiology (ASITN/SIR) collateral circulation grade, and perivascular space scores were compared between the two groups before and after treatment. Results: The total effective rate was 96.54% (56/58) in the study group and 83.04% (49/59) in the control group,with a statistically significant difference between the two groups (P<0.05). After treatment, the sub-item scores of traditional Chinese medicine syndrome including dizziness and blurred vision, chest pain, limb numbness, palpitations, shortness of breath, fatigue, spontaneous sweating,and the total traditional Chinese medicine syndrome scores decreased in both groups compared to before treatment (P<0.05),and the above scores in the study group were lower than those in the control group (P< 0.05). After treatment, there were no statistically significant differences in 24-hour mean SBP/DBP, daytime mean SBP/DBP, nighttime mean SBP/DBP, and SBP/DBP load values compared to before treatment in both groups (P> 0.05);the nighttime SBP/DBP reduction rates increased in both groups compared to before treatment (P<0.05),and the reduction rate in the study group was higher than that in the control group (P<0.05). After treatment,ACA Vm and MCA Vm levels increased in both groups compared to before treatment (P<0.05),and the levels in the study group were higher than those in the control group (P<0.05);ACA PI and MCA PI values decreased in both groups compared to before treatment (P<0.05),and the values in the study group were lower than those in the control group (P<0.05). After treatment,the ASITN/SIR collateral circulation grades improved in both groups compared to before treatment (P< 0.05),and the improvement in the study group was superior to that in the control group (P<0.05). After treatment, perivascular space scores decreased in both groups compared to before treatment (P<0.05),and the score in the study group was lower than that in the control group (P<0.05). There was no statistically significant difference in the incidence of adverse reactions between the two groups (P>0.05). Conclusion:Huayu Xiaoshuan Decoction combined with ACEI in the treatment of elderly patients with hypertension complicated by lacunar infarction can alleviate various clinical symptoms, effectively regulate blood pressure circadian rhythm, reduce blood pressure variability, improve cerebral blood perfusion,promote collateral circulation,reduce perivascular spaces,and enhance clinical efficacy.

    参考文献
    相似文献
    引证文献
引用本文

王燃冰,刘兰印,程杰.化瘀消栓汤联合血管紧张素转换酶抑制剂治疗老年高血压合并腔隙性脑梗死临床研究[J].新中医,2026,58(10):1-7

复制
分享
相关视频

文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期: 2026-05-28
  • 出版日期:
文章二维码